The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Colorectal tumor development is linked to Wnt signaling and Adenomatous Polyposis Coli (APC) gene mutations.
• Truncated APC proteins in human tumors typically retain beta-catenin binding repeats, complicating mechanistic studies.
• Mouse models offer a way to study varying APC genotypes and their impact on tumorigenesis.

Purpose of the Study:

• To investigate the impact of a suboptimal Apc genotype on colorectal tumorigenesis.
• To compare tumor development in a novel mouse model (Apc(1322T)) with the established Apc(Min) model.

Main Methods:

• A mouse model, Apc(1322T), was engineered to express an APC protein with one beta-catenin binding repeat.
• The Apc(1322T) mice were backcrossed to the C57BL/6J strain.
• Tumor development and characteristics were compared between Apc(1322T) and Apc(Min) mice.

Main Results:

• Both mouse models developed intestinal adenomas with loss of heterozygosity for the Apc allele.
• Apc(1322T) mice exhibited significantly more severe polyposis, including earlier onset, larger, more numerous, and more dysplastic adenomas.
• Apc(1322T) tumors showed increased Paneth cell differentiation and crypt fission, with paradoxically lower nuclear beta-catenin levels than Apc(Min) tumors.

Conclusions:

• The Apc(1322T) mutation results in submaximal beta-catenin signaling.
• This submaximal signaling enhances early tumor growth more effectively than the complete loss of beta-catenin binding repeats seen in Apc(Min) tumors.
• The Apc(1322T) model provides a valuable tool for studying APC's role in colorectal cancer progression.